{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:43:15Z","timestamp":1790109795330,"version":"4.0.1"},"reference-count":21,"publisher":"MDPI AG","issue":"24","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Background: Cardiovascular disease (CVD), driven primarily by atherosclerosis, is a major cause of morbidity and mortality among cancer patients. This study aims to evaluate the diagnostic value of [68Ga]Ga-FAPI-PET as a novel molecular imaging tool for atherosclerosis, compared with established, non-specific [18F]FDG. Methods: We retrospectively analyzed twenty patients with bladder cancer who underwent [68Ga]Ga-FAPI positron-emission tomography\/magnetic resonance (PET\/MR) and [18F]FDG positron emission tomography\/computed tomography (PET\/CT) at staging. The target-to-background ratio (TBRs) of both tracers were assessed along six arterial segments, and uptake patterns were compared between the two radiotracers. Additionally, associations between the intensity of PET-active lesions and certain CVD risk factors, as well as the intake of acetylsalicylic acid (ASA), were evaluated. Results: [68Ga]Ga-FAPI detects significantly more active arterial PET lesions and shows significantly higher uptake than [18F]FDG in the per-lesion analysis (TBRFAPI: 1.7 \u00b1 0.5 vs. TBRFDG: 1.4 \u00b1 0.2; difference 19%; p &lt; 0.001) and in the patient-based analysis (TBRFAPI: 1.7 \u00b1 0.4 vs. TBRFDG: 1.4 \u00b1 0.2; difference 19%; p = 0.018). Arterial hypertension (p &lt; 0.001), dyslipidemia (p &lt; 0.001), and particularly type 2 diabetes mellitus (p &lt; 0.001; difference 34%), were significantly associated with elevated [68Ga]Ga-FAPI expression compared to [18F]FDG uptake. ASA therapy was associated with a significant reduction in arterial [68Ga]Ga-FAPI expression than [18F]FDG (p = 0.02). Conclusions: [68Ga]Ga-FAPI-PET imaging, demonstrating superior detection of atherosclerotic activity compared to [18F]FDG, might be a promising molecular imaging marker for atherosclerosis.<\/jats:p>","DOI":"10.3390\/diagnostics15243099","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T13:17:07Z","timestamp":1764940627000},"page":"3099","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Feasibility of [68Ga]Ga-FAPI PET Molecular Imaging in Atherosclerosis Compared with [18F]FDG in Oncological Patients"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8018-3884","authenticated-orcid":false,"given":"Raffaella","family":"Calabretta","sequence":"first","affiliation":[{"name":"Division of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebru","family":"Atli","sequence":"additional","affiliation":[{"name":"Division of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara Katharina","family":"Geist","sequence":"additional","affiliation":[{"name":"Division of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6243-3370","authenticated-orcid":false,"given":"Dina","family":"Muin","sequence":"additional","affiliation":[{"name":"Division of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Zisser","sequence":"additional","affiliation":[{"name":"Division of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4409-8324","authenticated-orcid":false,"given":"Clemens P.","family":"Spielvogel","sequence":"additional","affiliation":[{"name":"Division of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Falkenbach","sequence":"additional","affiliation":[{"name":"Division of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Kretschmer-Chott","sequence":"additional","affiliation":[{"name":"Division of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Schmitl","sequence":"additional","affiliation":[{"name":"Division of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2591-1380","authenticated-orcid":false,"given":"Jutta","family":"Bergler-Klein","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0016-6233","authenticated-orcid":false,"given":"Xiang","family":"Li","sequence":"additional","affiliation":[{"name":"Division of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0614-6660","authenticated-orcid":false,"given":"Patrick","family":"Binder","sequence":"additional","affiliation":[{"name":"Division of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4222-4083","authenticated-orcid":false,"given":"Marcus","family":"Hacker","sequence":"additional","affiliation":[{"name":"Division of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,12,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jacc.2022.04.042","article-title":"Cardiovascular Disease Risk Among Cancer Survivors: The Atherosclerosis Risk in Communities (ARIC) Study","volume":"80","author":"Florido","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/ejhf.2017","article-title":"Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: A position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC)","volume":"22","author":"Pudil","year":"2020","journal-title":"Eur. J. Heart Fail."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1093\/eurheartj\/ehw272","article-title":"2016 ESC\/EAS Guidelines for the Management of Dyslipidemias","volume":"37","author":"Catapano","year":"2016","journal-title":"Eur. Heart J."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1177\/1074248413504994","article-title":"Inflammation and atherosclerosis--revisited","volume":"19","author":"Pant","year":"2014","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"ref_5","first-page":"598","article-title":"Atherosclerosis with Immune Checkpoint Inhibitor Therapy: Evidence, Diagnosis, and Management: JACC: CardioOncology State-of-the-Art Review","volume":"4","author":"Zanni","year":"2022","journal-title":"Cardio Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1007\/s00259-015-3259-3","article-title":"Position paper of the Cardiovascular Committee of the European Association of Nuclear Medicine (EANM) on PET imaging of atherosclerosis","volume":"43","author":"Bucerius","year":"2016","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e012174","DOI":"10.1161\/CIRCIMAGING.120.012174","article-title":"Effect of Liraglutide on Arterial Inflammation Assessed as [18F]FDG Uptake in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial","volume":"14","author":"Ripa","year":"2021","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e15132","DOI":"10.1111\/dme.15132","article-title":"Systematic review of the barriers and facilitators to dietary modification in people living with type 2 diabetes and pre-diabetes from South Asian ethnic populations","volume":"40","author":"Rai","year":"2023","journal-title":"Diabet. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"948","DOI":"10.2967\/jnumed.121.262863","article-title":"Feasibility of In Vivo Imaging of Fibroblast Activation Protein in Human Arterial Walls","volume":"63","author":"Wu","year":"2022","journal-title":"J. Nucl. Med."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Kuret, T., and Sodin-\u0160emrl, S. (2021). The Role of Fibroblasts in Atherosclerosis Progression [Chapter]. Biochemistry, IntechOpen. Available online: https:\/\/www.intechopen.com\/chapters\/77138.","DOI":"10.5772\/intechopen.98546"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1053\/j.semnuclmed.2024.02.006","article-title":"FAPI-PET in Cardiovascular Disease","volume":"54","author":"Higuchi","year":"2024","journal-title":"Semin. Nucl. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1007\/s00259-023-06245-w","article-title":"Molecular imaging of arterial fibroblast activation protein: Association with calcified plaque burden and cardiovascular risk factors","volume":"50","author":"Kosmala","year":"2023","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_13","first-page":"469","article-title":"Comparison of (18)F-FDG PET\/CT and PET\/MRI in patients with multiple myeloma","volume":"5","author":"Sachpekidis","year":"2015","journal-title":"Am. J. Nucl. Med. Mol. Imaging"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1161\/CIRCULATIONAHA.120.048708","article-title":"Immune Checkpoint Inhibitor Therapy Induces Inflammatory Activity in Large Arteries","volume":"142","author":"Calabretta","year":"2020","journal-title":"Circulation"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1016\/j.jacc.2006.05.076","article-title":"In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients","volume":"48","author":"Tawakol","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s11883-012-0264-x","article-title":"Molecular imaging in atherosclerosis: FDG PET","volume":"14","author":"Rosenbaum","year":"2012","journal-title":"Curr. Atheroscler. Rep."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.jacc.2019.06.057","article-title":"18Fluorodeoxyglucose Accumulation in Arterial Tissues Determined by PET Signal Analysis","volume":"74","author":"Tolbod","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3886","DOI":"10.1007\/s00259-021-05362-8","article-title":"Diagnostic value of [18F]FDG-PET\/CT for treatment monitoring in large vessel vasculitis: A systematic review and meta-analysis","volume":"48","author":"Treglia","year":"2021","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"H\u00f8ilund-Carlsen, P.F., Piri, R., Madsen, P.L., Revheim, M.E., Werner, T.J., Alavi, A., Gerke, O., and Sturek, M. (2022). Atherosclerosis Burdens in Diabetes Mellitus: Assessment by PET Imaging. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms231810268"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Cui, Y., Wang, Y., Wang, S., Du, B., Li, X., and Li, Y. (2023). Highlighting Fibroblasts Activation in Fibrosis: The State-of-The-Art Fibroblast Activation Protein Inhibitor PET Imaging in Cardiovascular Diseases. J. Clin. Med., 12.","DOI":"10.3390\/jcm12186033"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"20140119","DOI":"10.1259\/bjr.20140119","article-title":"Partial-volume effect correction in positron emission tomography brain scan image using super-resolution image reconstruction","volume":"88","author":"Meechai","year":"2015","journal-title":"Br. J. Radiol."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/15\/24\/3099\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T13:51:24Z","timestamp":1764942684000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/15\/24\/3099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":21,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["diagnostics15243099"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics15243099","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,5]]}}}